Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions
Advanced Science · 2026-03 · 13 (16)
DOI: 10.1002/advs.202520653 ↗At a glance
Übersichtsarbeit in Advanced Science, published online on 2026-02-09. Written by Yiqi Zhao and 4 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, P.…. Major MEDLINE topics: Protein Processing, Post-Translational. Cited 2 times so far (Crossref); 109 references. The full text is freely available (open access, CC BY 4.0). Funded by: Beijing Natural Science Foundation, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (original language)
Parallel to their roles in regulating receptor activation, mounting evidence suggests that monoamines are involved in protein post‐translational modification, which regulates the physiological function of the nervous system and various pathophysiologically relevant conditions. These modifications, primarily including serotonylation, dopaminylation, and histaminylation, occur on both histone and non‐histone proteins, thereby modulating gene transcription and protein function. This review comprehensively summarizes the types of monoaminylation, the catalytic enzymes and molecular mechanisms, and the corresponding monoamine transporters. Furthermore, we categorize and discuss the roles of monoaminylation across the human body in health and disease, highlighting their functional implications and therapeutic potential. We emphasize the need for precise methodologies to modulate monoamine levels in the context of pathological processes across various diseases. Finally, we outline persistent challenges in the field and suggest promising directions for future research, aiming to facilitate both mechanistic insight and translational applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, P. R. China.
- Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Science, Inner Mongolia Medical University, Hohhot, Inner Mongolia, P. R. China.
ORCID profiles: Yan-Dong Wang
Funding
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- National Key R&D Program of China
- Natural Science Foundation of Beijing Municipality
- National Key Research and Development Program of China
Cite
APA
Zhao, Y., Zhang, H., Yang, Y., Chen, W. D., & Wang, Y. D. (2026). Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions. Advanced Science, 13(16). https://doi.org/10.1002/advs.202520653
Vancouver
Zhao Y, Zhang H, Yang Y, Chen WD, Wang YD. Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions. Advanced Science. 2026;13(16). doi:10.1002/advs.202520653
BibTeX
@article{Zhao2026,
author = {Zhao, Yiqi and Zhang, Hongli and Yang, Yating and Chen, Wei-Dong and Wang, Yan-Dong},
title = {Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {16},
doi = {10.1002/advs.202520653}
}
EUVIMED